Background: Red yeast, Xanthophyllomyces dendrorhous (Phaffia rhodozyma) is the only yeast known to produce astaxanthin, an anti-oxidant isoprenoid (carotenoid) that is widely used in the aquaculture, food, pharmaceutical and cosmetic industries. Recently, the potential of this microorganism as a platform cell factory for isoprenoid production has been recognized because of high flux through its native terpene pathway. Addition of mevalonate, the common precursor for isoprenoid biosynthesis, has been shown to be critical to enhance the astaxanthin content in X. dendrorhous. However, addition of mevalonate is unrealistic during industrial isoprenoid production because it is an unstable and costly chemical. Therefore, up-regulating the intracellular mevalonate supply by enhancing the mevalonate synthetic pathway though genetic engineering is a promising strategy to improve isoprenoid production in X. dendrorhous. However, a system to strongly express multiple genes has been poorly developed for X. dendrorhous. Results: Here, we developed a multiple gene expression system using plasmids containing three strong promoters in X. dendrorhous (actin, alcohol dehydrogenase and triose-phosphate isomerase) and their terminators. Using this system, three mevalonate synthetic pathway genes encoding acetoacetyl-CoA thiolase, HMG-CoA synthase and HMG-CoA reductase were overexpressed at the same time. This triple overexpressing strain showed an increase in astaxanthin production compared with each single overexpressing strain. Additionally, this triple overexpression of mevalonate synthetic pathway genes together with genes involved in β-carotene and astaxanthin synthesis showed a synergetic effect on increasing astaxanthin production. Finally, astaxanthin production was enhanced by 2.1-fold compared with the parental strain without a reduction of cell growth. Conclusions: We developed a system to strongly overexpress multiple genes in X. dendrorhous. Using this system, the synthetic pathway of mevalonate, a common substrate for isoprenoid biosynthesis, was enhanced, causing an increase in astaxanthin production. Combining this multiple gene overexpression system with a platform strain that overproduces mevalonate has the potential to improve industrial production of various isoprenoids in X. dendrorhous.
Background
Carotenoids are widely distributed in nature, and are exclusively synthesized by plants and microorganisms [1] . Carotenoids belong to the natural compounds class of terpenes (isoprenoids) [2] . Bioproduction of pharmaceutically important carotenoids such as artemisinin and Taxol have been accomplished through genetic engineering of wellcharacterized microorganisms such as Saccharomyces cerevisiae and Escherichia coli [3, 4] . However, Melillo, et al., showed the potential of the red yeast, Phaffia rhodozyma (sexual form, Xanthophyllomyces dendrorhous), as a platform microorganism for isoprenoids production because of the higher flux through its native terpene pathway compared with S. cerevisiae and E. coli [5] .
X. dendrorhous has been studied as a promising candidate microorganism for maximizing production of a carotenoid, astaxanthin (3, 3′-dihydroxy-β, β-carotene-4, 4′-dione; C 40 H 52 O 4 ) for use for fine chemicals such as food, pharmaceuticals and cosmetics because of its antioxidant property [6, 7] . In fungi, including X. dendrorhous, all isoprenoids are biosynthesized from a common precursor, mevalonate, via the terpene pathway ( Figure 1 ). It has been shown that supplementation of mevalonate was critical to increase the astaxanthin content in X. dendrorhous [8] . However, mevalonate addition is not economically feasible for industrial production because it is an unstable and expensive chemical. Thus, increasing the supply of intracellular mevalonate by metabolic engineering would be a valuable way to increase isoprenoid production because it negates the need and the cost of externally added mevalonate. It has already been reported that reducing the carbon flow to the fatty acid and ergosterol biosynthesis pathways ( Figure 1 ) enhances astaxanthin production due to the increase in carbon flow to mevalonate biosynthesis pathway [9] . However, this made cell growth slower because fatty acids and ergosterol are important structural components of the cell membrane. This suggests that strengthening the mevalonate synthetic pathway by overexpressing genes encoding enzymes involved in the mevalonate synthetic pathway is a promising approach to enhance biosynthesis of astaxanthin or any other isoprenoids without additional compounds and effects on cell growth in X. dendrorhous. Indeed, it has already been reported that overexpressing hmgR, which is one of genes involved in the mevalonate synthetic pathway, under its original promoter was critical to enhance the astaxanthin content in X. dendrorhous [10] .
We previously identified several strong promoters of X. dendrorhous using GFP as a protein expression level indicator [7] . In this study, we developed a system to overexpress multiple genes under these strong promoters in X. dendrorhous. Overexpression of three genes involved in the mevalonate synthetic pathway using this system improved astaxanthin production in X. dendrorhous. Furthermore, simultaneous overexpression of these mevalonate synthetic pathway genes with genes involved in the β-carotene and astaxanthin synthetic pathways synergistically enhanced the biosynthesis of astaxanthin; this production of astaxanthin indicates the ability of this strain to produce high quantities of isoprenoids. Combining the mevalonate producing strain and the multiple gene overexpression system developed in this study gives us powerful tools to improve production of various isoprenoids in X. dendrorhous.
Results and discussion
Single gene overexpression of mevalonate synthetic pathway genes
We constructed single gene overexpression vectors to enhance the mevalonate synthetic pathway (Figure 2a ). As shown in Figure 1 [11] . It was recently reported that overexpressing hmgR in X. dendrorhous increased astaxanthin production [10] . However, the effect of the other two genes involved in the mevalonate synthetic pathway, acaT and hmgS, on isoprenoid production was not evaluated.
In this study, we cloned and overexpressed acaT and hmgS to evaluate their effect on astaxanthin biosynthesis in X. dendrorhous. Previously, we showed the gdh promoter was an efficient promoter that showed higher expression level of target genes using GFP as a protein expression level indicator [7] . Therefore, we selected the gdh promoter to overexpress the acaT, hmgS and hmgR genes (Figure 2a ). To compare the influence of single overexpression of acaT, hmgS and hmgR on astaxanthin production, three plasmids encoding each gene under the gdh promoter were constructed. X. dendrorhous mutant strains overexpressing acaT, hmgS or hmgR were obtained by transformation using these plasmids. We compared cell concentration, cellular astaxanthin content and volumetric astaxanthin concentration of these three mutant strains and the vector control strain ( Figure 3 ). As shown in Figure 3a , the strains overexpressing hmgS and hmgR showed statistically higher final cell growth compared with the vector control strain. However, the acaT overexpressing strain showed almost equal cell growth to the control strain. The intracellular astaxanthin content of the strains overexpressing acaT (0.32 mg/g-cell) and hmgS (0.33 mg/g-cell) was 1.3-fold higher than that of the control strain (0.26 mg/g-cell) after 72 h of culture ( Figure 3b ). These values were equal to that of the strain overexpressing hmgR (0.31 mg/g-cell), which was previously shown to be critical to enhance the astaxanthin content [10, 11] . With the increased intracellular astaxanthin content and normal cell growth in the strains overexpressing acaT, hmgS or hmgR, the volumetric astaxanthin concentrations (2.1-2.2 mg/L) after 72 h were equally increased compared with that of the control strain (1.6 mg/L) by about 1.3fold ( Figure 3c ). This new insight proposes that the bottle-neck for intracellular mevalonate supply is not solely the reaction catalyzed by HmgR, but all three reactions involved in mevalonate biosynthesis reactions catalyzed by AcaT, HmgS and HmgR. This result is consistent with the previous result that indicated the presence of other rate-limiting enzymes from HmgR for isoprenoids biosynthesis in plant [12] . 
Overexpression of multiple mevalonate synthetic pathway genes
Equal enhancement of astaxanthin production by each of the genes involved in the mevalonate synthetic pathway indicates the equal contribution of each reaction in this pathway to astaxanthin production in X. dendrorhous. Thus, to enhance astaxanthin production by improving mevalonate production, overexpression of multiple mevalonate synthetic pathway genes would be critical. To achieve this, plasmids including either G418 or Zeocin resistant genes and three cloning sites for target genes under strong promoters were constructed (Figure 2b) . The strong promoters, Pact, Padh4 and Ptpi were identified by our previous study [7] . Using this multiple gene expression system, construction of a strain overexpressing three mevalonate synthetic pathway genes (acaT, hmgS and hmgR) and a strain overexpressing only hmgR was carried out. Cell concentration, intracellular astaxanthin content and volumetric astaxanthin concentration were compared with the vector control strain after 72 h of culture ( Table 1 ). All strains showed almost the same cell growth. The triple overexpressing strain, which overexpresses acaT/hmgS/hmgR, showed 1.4-fold higher volumetric astaxanthin production (2.5 mg/L) compared with that of the control strain (1.6 mg/l), although the hmgR single overexpressing strain still showed slightly higher astaxanthin production than the control strain (2.2 mg/L). As the result, triple overexpression of acaT, hmgS and hmgR using the multiple gene expression system developed in this study synergistically improved astaxanthin production without reducing cell growth.
Combinatorial overexpression of genes involved in mevalonate, β-carotene and astaxanthin synthetic pathways CrtE catalyzes biosynthesis of geranylgeranyl-pyrophosphate (GGPP) from farnesyl-pyrophosphate (FPP) in the βcarotene synthetic pathway in X. dendrorhous (Figure 1 ). Breitenbach, et al., reported that self-cloning and overexpression of the crtE gene increased astaxanthin production [13] . To test the synergetic effect on astaxanthin production of enhancing synthetic pathways of mevalonate, β-carotene and astaxanthin, the crtE gene was overexpressed in either the parental strain or the acaT/hmgS/hmgR overexpressing strain using the multiple gene overexpression system. Comparing the volumetric concentration of astaxanthin produced by these strains, crtE overexpression increased the astaxanthin production in both the strains by about 1.3-fold ( Figure 4 ). Additionally, combined overexpression of crtE and crtS, a gene in the astaxanthin synthetic pathway, synergistically increased astaxanthin production in both the parental strain and the acaT/hmgS/hmgR overexpressing strain by about 1.6-fold. The astaxanthin production of the acaT/ hmgS/hmgR/crtE/crtS overexpressing strain after 72 h reached 3.0 mg/L, which was 2.1-fold higher compared with the control strain (1.4 mg/L). This result indicates that the increased mevalonate production platform strain overexpressing acaT/hmgS/hmgR has potential to enhance isoprenoids production when combined with additional overexpression of appropriate genes, depending on the target isoprenoid, using the multiple gene overexpression system developed in this study.
Conclusion
In this study, we focused on developing a system to strongly express multiple genes in X. dendrorhous to improve isoprenoid production. We constructed two types of multiple gene expression vectors including either a G418 resistance gene or Zeocin resistance gene (Figure 2b) . These vectors include three cloning sites under different strong promoters, Padh4, Pact and Ptpi, which were evaluated in our previous study [7] . Using this multiple gene overexpression system, we succeeded in synergistically improving astaxanthin production in X. dendrorhous through metabolic engineering to overexpress the three mevalonate synthetic pathway genes acaT, hmgS and hmgR, along with a β-carotene synthetic pathway gene (crtE) and an astaxanthin synthetic pathway gene (crtS). Astaxanthin is an end product of the isoprenoid synthetic pathway and its synthesis in this engineered strain indicates its ability to produce isoprenoids. Therefore, genetic engineering using the developed system to strongly express multiple target genes in a platform strain overproducing mevalonate has the potential to improve production of various value-added isoprenoids in X. dendrorhous.
Methods

Strains and media
NovaBlue (Novagen, Madison, WI, USA) was used as the Escherichia coli host strain for recombinant DNA manipulation. Xanthophyllomyces dendrorhous (NBRC 10129) was used as the parental host strain for gene expression. E. coli transformants were grown in LB medium (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L sodium chloride) supplemented with 100 μg/mL ampicillin. Transformants of X. dendrorhous were cultured in YM medium (5 g/L tryptone, 3 g/L yeast extract, 3 g/L malt extract and 10 g/L glucose). Yeast extract and malt extract were purchased from Becton Dickinson (Sparks, MD, USA). Other chemicals were obtained from Nacalai Tesque (Kyoto, Japan) or Wako Chemicals (Osaka, Japan).
Plasmid construction
Target genes were cloned by PCR using KOD-Plus-Neo DNA polymerase (Toyobo, Osaka, Japan). Nucleotide sequences of cloning primers for target genes are shown in Additional file 1. Construction of single or multiple gene expression vectors is shown in Figure 2 . Nucleotide sequences of acaT and hmgS were detected by comparison to known sequences of Cryptococcus neoformans, whose amino acid sequence of hmgR has high homology with that of X. dendrorhous [5] , using the BLASTX program through the Genome Net web site (http://www.genome.jp/tools/blast/). The sequences of acaT and hmgS have been registered in the GenBank with the accession numbers AB919149 and AB919150, respectively. Both these genes and the hmgR gene [10] were amplified by PCR from X. dendrorhous genomic DNA. The forward primer and reverse primer sets used for these amplifications were acaT-fw/acaT-rv, hmgSfw/hmgS-rv and hmgR-fw/hmgR-rv, respectively. SpeI sites were introduced into the forward primers and StuI sites were introduced into the reverse primers. The amplified fragments from acaT, hmgS and hmgR were digested with SpeI/StuI and inserted into the SpeI/StuI site of pKF-G418-G (Figure 2a ) to construct pKF-G418-G-acaT, pKF-G418-G-hmgS and pKF-G418-G-hmgR, respectively. The G-418 resistant multiple gene expression vector, pKF-G418-AAT (Figure 2b) , was constructed by cloning the act promoter and terminator (Pact/Tact), Padh4/Tadh4 and Ptpi/Ttpi from X. dendrorhous genomic DNA by PCR using the In-Fusion® HD Cloning Kit (Takara, Shiga, Japan). The acaT, hmgS and hmgR genes were also amplified by PCR from X. dendrorhous genomic DNA using forward primer and reverse primer sets acaT-MCS3-fw/acaT-MCS3-rv, hmgS-MCS2-fw/hmgS-MCS2-rv and hmgR-MCS1-fw/hmgR-MCS1-rv, respectively. The AscII/SpeI, SacII/PacI and MfeI/MfeI restriction sites were introduced into these forward/reverse primer sets. The amplified fragments from hmgR were digested with MfeI and inserted into the MfeI site in MCS1 of pKF-G418-AAT to construct pKF-G418-AAT-hmgR. The amplified fragment from hmgS was digested with SacII/PacI and inserted into the SacII/ PacI site in MCS2 of pKF-G418-AAT-hmgR to construct pKF-G418-AAT-hmgR/hmgS. The amplified fragment from acaT was digested with AscII/SpeI and inserted into the AscII/SpeI site in MCS3 of pKF-G418-AAT-hmgR/hmgS to construct pKF-G418-AAT-hmgR/hmgS/acaT.
To construct the Zeocin resistant multiple gene expression vector pKF-Zeo-AAT, the Zeocin resistance gene was amplified by PCR from pREMI-z (Novagen) using the Zeo-BsiWI-fw/Zeo-BsiWI-rv forward and reverse primer set. The resulting Zeocin resistant gene fragment was cloned into the pKF-G418-AAT vector lacking the G418 resistance gene using the In-Fusion® HD Cloning Kit. A β-carotene synthetic pathway gene, crtE, and an astaxanthin synthetic pathway gene crtS were amplified by PCR from X. dendrorhous genomic DNA using forward primer and reverse primer sets crtE-MCS1-fw/crtE-MCS1-rv and crtS-MCS2-fw/crtS-MCS2rv, respectively. MfeI/MfeI and SacII/PacI were introduced into these forward/reverse primer sets. The amplified fragments from crtE were digested with MfeI and inserted into the MfeI site in MCS1 of pKF-Zeo-AAT to construct pKF-Zeo-AAT-crtE. The amplified fragment from crtS was digested with SacII/PacI and inserted into the SacII/PacI site in MCS2 of pKF-Zeo-AAT-crtE to construct pKF-Zeo-AAT-crtE/crtS.
Yeast transformation
All constructed plasmids were digested with NdeI at both the ends of rDNA regions ( Figure 2 ) and transformed into the X. dendrorhous host strains to construct the target gene overexpressing strains. Transformation was carried out based on the method described in previous reports [14, 15] with some modifications for construction of competent cells: X. dendrorhous parental strain was grown in 5 mL liquid YM medium at 22°C with agitation at 250 rpm for 24 h. An adequate volume of each culture was inoculated into 150 mL liquid YM medium to achieve an initial OD 600 value of 0.03. Cultures were then grown at 22°C with agitation at 120 rpm for 16.5 h.
The NdeI digested plasmids, pKF-G418-AAT, pKF-G418-AAT-acaT, pKF-G418-AAT-hmgR and pKF-G418-AAT-hmgS were transformed into the parental X. dendrorhous host strain to construct the vector control strain, acaT overexpressing strain, hmgS overexpressing strain and hmgR overexpressing strain, respectively, and compare their cell growth and astaxanthin production ( Figure 3 ). The NdeI digested plasmids, pKF-G418-AAT, pKF-G418-AAT-hmgR and pKF-G418-AAT-acaT/hmgR/ hmgS were transformed into the parental X. dendrorhous host strain to construct the vector control strain, hmgR single overexpressing strain and acaT/hmgR/hmgS multiple overexpressing strain, respectively, and compare their cell growth and astaxanthin production ( Table 1 ). The NdeI digested plasmids, pKF-Zeo-AAT, pKF-Zeo-AAT-crtE and pKF-Zeo-AAT-crtE/crtS were transformed into the pKF-G418-AAT vector control strain or the acaT/ hmgR/hmgS multiple overexpressing strain to construct the vector control strain, crtE overexpressing strain, crtE/ crtS overexpressing strain, acaT/hmgR/hmgS overexpressing strain, acaT/hmgR/hmgS/crtE overexpressing strain and acaT/hmgR/hmgS/crtE/crtS overexpressing strain and compare their cell growth and astaxanthin production ( Figure 4) .
Cultivation of X. dendrorhous strains X. dendrorhous strains overexpressing target genes were grown in 5 mL liquid YM medium containing 40 μg/mL G418 and 200 μg/mL Zeocin if needed in test tubes at 22°C with agitation at 250 rpm for 72 h. An adequate volume of each culture was inoculated into 80 mL liquid YM medium in a Sakaguchi Flask to achieve an initial OD 600 value of 0.15. Cells were then grown at 22°C with agitation at 120 rpm for less than 72 h.
Analytical methods
Cell concentration was measured as the optical density at 600 nm after culture for the appropriate time. To measure the intracellular astaxanthin content of X. dendrorhous mutants, harvested cells were suspended into 1 mL acetone. The cells were broken using a bead shocker (Shake Master
